The $4.0M note issuance provides a cash runway extension but increases dilution risk for a $14M market cap company. Watch for the definitive proxy statement detailing the potential Celadon merger and CVR terms; the $60.0M upside is contingent on SENTI-202 milestones, which are binary and distant. Monitor cash burn rate and any further draws under the securities purchase agreement.
Price Chart
Executive Summary
Senti Biosciences issued an additional $4.0M in Senior Secured Convertible Notes to Celadon Partners under a previously announced securities purchase agreement. The filing also discloses a potential merger transaction where a Celadon affiliate would merge into a subsidiary, with stockholders receiving a contingent value right worth up to $60.0M tied to SENTI-202 milestones. The $4.0M debt draw provides near-term cash but increases leverage and potential dilution for a micro-cap biotech with a $14M market cap.
Key Facts
- Issued $4.0M in Senior Secured Convertible Notes to Celadon Partners SPV 24 on August 14, 2026.
- The notes are part of a Securities Purchase Agreement dated April 27, 2026.
- A potential transaction could see a Celadon affiliate merge into Senti Holdings, with stockholders receiving a contingent value right of up to $60.0M based on SENTI-202 milestones.
- Company has a $14M market cap, making the $4.0M debt issuance material relative to equity value.
Financial Impact
$4.0M in new senior secured convertible debt issued; potential $60.0M contingent value right for stockholders tied to SENTI-202 milestones.
Risk Factors
- Dilution from conversion of $4.0M in convertible notes at a micro-cap valuation.
- Execution risk on SENTI-202 regulatory and sales milestones for the $60.0M CVR.
- Potential shareholder dilution from additional note issuances beyond the exchange cap, requiring a shareholder vote.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-058258 |
| Document: 0001628280-26-058258-index-headers.html | 0001628280-26-058258 |
| Document: 0001628280-26-058258-index.html | 0001628280-26-058258 |
| Document: 0001628280-26-058258.txt | 0001628280-26-058258 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | DEFA14A | $0.2408 $0.2175 | ▼ −9.68% | ▼ −10.13% | $0.1778 (−26.16%) |
Oct 13, 2026 12d ago | 8-K | $0.2408 $0.2175 | ▲ +9.68% | ▲ +10.13% | $0.1778 (+26.16%) |
Sep 25, 2026 4w ago | EFFECT | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1778 (+46.01%) |
Sep 24, 2026 4w ago | DEFM14A | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1778 (+46.01%) |
Sep 22, 2026 4w ago | S-3/A | $0.3156 $0.3075 | ▲ +2.57% | ▲ +1.38% | $0.1778 (+43.66%) |
Sep 10, 2026 6w ago | S-3/A | $0.3060 $0.3200 | ▼ −4.58% | ▼ −4.80% | $0.1778 (+41.90%) |
Sep 4, 2026 7w ago | DEFA14A | $0.3326 $0.3021 | ▼ −9.17% | ▼ −7.96% | $0.1778 (−46.54%) |
Sep 4, 2026 7w ago | 8-K | $0.3326 $0.3021 | ▲ +9.17% | ▲ +7.96% | $0.1778 (+46.54%) |
Aug 20, 2026 9w ago | 8-K | $0.3886 $0.3770 | ▲ +2.99% | ▲ +3.46% | $0.1778 (+54.25%) |
Jul 16, 2026 14w ago | S-3/A | $0.4597 $0.4266 | ▲ +7.20% | ▲ +5.53% | $0.1778 (+61.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers